139 related articles for article (PubMed ID: 12369651)
1. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
[TBL] [Abstract][Full Text] [Related]
2. Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria.
Torre D; Speranza F; Giola M; Matteelli A; Tambini R; Biondi G
Clin Diagn Lab Immunol; 2002 Mar; 9(2):348-51. PubMed ID: 11874876
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
Imamura Y; Kurokawa MS; Yoshikawa H; Nara K; Takada E; Masuda C; Tsukikawa S; Ozaki S; Matsuda T; Suzuki N
Clin Exp Immunol; 2005 Feb; 139(2):371-8. PubMed ID: 15654837
[TBL] [Abstract][Full Text] [Related]
4. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
5. The Role of Th17 Cells in the Pathogenesis of Behcet's Disease.
Nanke Y; Yago T; Kotake S
J Clin Med; 2017 Jul; 6(7):. PubMed ID: 28753995
[TBL] [Abstract][Full Text] [Related]
6. Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behçet disease: a prospective registry study.
Hirahara L; Kirino Y; Soejima Y; Iizuka Y; Yoshimi R; Fujieda Y; Atsumi T; Tono T; Kobayashi D; Meguro A; Takeuchi M; Sakamaki K; Takeno M; Mizuki N; Nakajima H
Front Immunol; 2024; 15():1354969. PubMed ID: 38686380
[TBL] [Abstract][Full Text] [Related]
7. Cytokines and Behcet's disease.
Zhou ZY; Chen SL; Shen N; Lu Y
Autoimmun Rev; 2012 Aug; 11(10):699-704. PubMed ID: 22197901
[TBL] [Abstract][Full Text] [Related]
8. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
[TBL] [Abstract][Full Text] [Related]
9. Th17 cells in Behçet's disease: a new immunoregulatory axis.
Hamzaoui K
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S71-6. PubMed ID: 21968241
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.
Akman-Demir G; Tüzün E; Içöz S; Yeşilot N; Yentür SP; Kürtüncü M; Mutlu M; Saruhan-Direskeneli G
Cytokine; 2008 Dec; 44(3):373-6. PubMed ID: 19010690
[TBL] [Abstract][Full Text] [Related]
11. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease.
Direskeneli H; Keser G; D'Cruz D; Khamashta MA; Akoğlu T; Yazici H; Yurdakul S; Hamuryudan V; Ozgün S; Goral AJ
Clin Rheumatol; 1995 Jan; 14(1):55-61. PubMed ID: 7743745
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of pain and their relationship to disease activity in UK patients with Behçet's syndrome: a prospective cohort study.
Plant K; Goebel A; Nair J; Moots R; Chadwick L; Goodson N
Br J Pain; 2023 Dec; 17(6):560-568. PubMed ID: 37969132
[TBL] [Abstract][Full Text] [Related]
13. The roles of immune cells in Behçet's disease.
Hu D; Guan JL
Adv Rheumatol; 2023 Oct; 63(1):49. PubMed ID: 37814339
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis of Behçet's disease.
Al-Obeidi AF; Nowatzky J
Clin Immunol; 2023 Aug; 253():109661. PubMed ID: 37295542
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T; Okubo Y; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Uehara N; Handa T; Tanaka M; Zhang W; Paris M; Murakami M
Am J Clin Dermatol; 2023 Sep; 24(5):837-847. PubMed ID: 37233897
[TBL] [Abstract][Full Text] [Related]
16. The Expanding Spectrum of Autoinflammatory Diseases.
Migita K; Fujita Y; Asano T; Sato S
Intern Med; 2023; 62(1):43-50. PubMed ID: 36596474
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's disease.
Celik F; Coteli E; Gul FC; Ozsoy E; Kobat SG; Karagoz ZK; Aydin S; Ugur K; Yardim M; Sahin İ; Yalcin MH; Akkoc RF; Aydin S
Int Ophthalmol; 2022 Nov; 42(11):3321-3331. PubMed ID: 35622217
[TBL] [Abstract][Full Text] [Related]
18. The Roles of Monocytes and Macrophages in Behçet's Disease With Focus on M1 and M2 Polarization.
Hirahara L; Takase-Minegishi K; Kirino Y; Iizuka-Iribe Y; Soejima Y; Yoshimi R; Nakajima H
Front Immunol; 2022; 13():852297. PubMed ID: 35359926
[TBL] [Abstract][Full Text] [Related]
19. Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.
Nguyen A; Upadhyay S; Javaid MA; Qureshi AM; Haseeb S; Javed N; Cormier C; Farooq A; Sheikh AB
Inflamm Intest Dis; 2021 Dec; 6(4):175-185. PubMed ID: 35083283
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Behçet's disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report.
Shimizu H; Sato S; Suzuki T; Sasajima T; Takahata Y; Shinohara N; Hideshima K; Yokokawa Y; Matsuhashi N; Ichii O; Tai M; Ejiri Y; Yano K; Ikezoe T; Ohira H; Migita K
BMC Gastroenterol; 2021 Dec; 21(1):488. PubMed ID: 34930121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
